SCHEMBL30712075

SCHEMBL30712075

CC(=O)Oc1c(C)ccc2[nH]ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ SLC22A6 Q4U2R8 1/20 0.42
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ ACHE P22303 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ RHEB Q15382 1/20 0.37
▸ P2RX7 Q99572 1/20 0.37
▸ TUBB4A P04350 1/20 0.37
▸ TUBB P07437 1/20 0.37
▸ TUBA3C P0DPH7 1/20 0.37
▸ TUBA1B P68363 1/20 0.37
▸ TUBA4A P68366 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29223283 0.83 RHEB (0.53) KDM4EHSD17B10HTTGAATP53
SCHEMBL28025570 0.79 SLC22A6 (0.50) KDM4EHSD17B10HTTGAAALDH1A1
SCHEMBL30483746 0.78 RHEB (0.41) KDM4EALDH1A1MTNR1AMTNR1BACHE
SCHEMBL6270065 0.78 RHEB (0.41) KDM4EALDH1A1MTNR1AMTNR1BACHE
SCHEMBL16265058 0.77 KDM4E (0.59) KDM4EHSD17B10HTTGAATP53
SCHEMBL594038 0.72 SLC22A6 (0.63) KDM4EHSD17B10TP53ALDH1A1HPGD
SCHEMBL29511854 0.72 SLC22A6 (0.63) KDM4EHSD17B10TP53ALDH1A1HPGD
SCHEMBL29783527 0.71 NOTUM (0.41) KDM4EHSD17B10ALDH1A1HPGDMTNR1A
SCHEMBL27222251 0.71 NOTUM (0.41) KDM4EHSD17B10ALDH1A1HPGDMTNR1A
SCHEMBL16450253 0.71 KDM4E (0.53) KDM4EHSD17B10HTTGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
EP-4551212-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024035757-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2024-02-15 — — WO disclosed
Send feedback